![Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.,Scientific Reports - X-MOL Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.,Scientific Reports - X-MOL](https://xpic.x-mol.com/20191101%2F10.1038_s41598-019-52414-z.jpg)
Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.,Scientific Reports - X-MOL
![POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East - Siraj - 2020 - Molecular Genetics & Genomic Medicine - Wiley Online Library POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East - Siraj - 2020 - Molecular Genetics & Genomic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aa7a961c-c504-4093-802a-5749beb6c878/mgg31368-fig-0002-m.jpg)
POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East - Siraj - 2020 - Molecular Genetics & Genomic Medicine - Wiley Online Library
![POLD1 Germline Mutations in Patients Initially Diagnosed with Werner Syndrome. - Abstract - Europe PMC POLD1 Germline Mutations in Patients Initially Diagnosed with Werner Syndrome. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4684254/bin/nihms-743019-f0001.jpg)
POLD1 Germline Mutations in Patients Initially Diagnosed with Werner Syndrome. - Abstract - Europe PMC
![POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02422-1/MediaObjects/13046_2022_2422_Fig1_HTML.png)
POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02422-1/MediaObjects/13046_2022_2422_Fig2_HTML.png)
POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![IJMS | Free Full-Text | POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma IJMS | Free Full-Text | POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma](https://www.mdpi.com/ijms/ijms-24-06849/article_deploy/html/images/ijms-24-06849-g005.png)
IJMS | Free Full-Text | POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma
![Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor. - Abstract - Europe PMC Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7867935/bin/atm-09-02-129-f2.jpg)
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor. - Abstract - Europe PMC
![Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1 - ScienceDirect Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0091674919313223-fx1.jpg)
Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1 - ScienceDirect
![The POLD1R689W variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitors | Scientific Reports The POLD1R689W variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitors | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-76033-1/MediaObjects/41598_2020_76033_Fig1_HTML.png)
The POLD1R689W variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitors | Scientific Reports
Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
![High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation | Modern Pathology High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41379-019-0430-6/MediaObjects/41379_2019_430_Fig1_HTML.png)
High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation | Modern Pathology
![What is POLD1 Gene Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome NGS Genetic DNA Test ? What is POLD1 Gene Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome NGS Genetic DNA Test ?](https://dnalabsindia.com/uploads/images/60b1d0640fe62.jpg)